COVID Intel - by William Makis (McGill Medicine)

COVID Intel - by William Makis (McGill Medicine)

Vitamin D TREATMENT for Hospitalized COVID-19 patients works! NEW Sep.2023 Japanese Study shows 67% lower death, 78% lower disease progression, 75% lower O2 - 10 recent studies reviewed

William Makis's avatar
William Makis
Sep 16, 2023
∙ Paid

I will review several studies on Vitamin D treatment of patients hospitalized for COVID-19:

  • 2023 Sep (Ogasawara et al) Japan - Late treatment alfacalcidol

  • 2023 July (Mingiano et al) Italy - Late treatment calcifediol

  • 2022 Oct (Hafezi) - Dubai - ICU pt treatment D3 50,000 IU weekly

  • 2022 Aug (Sharif-Askari) UAE - ICU pt treatment D3 50,000 IU weekly

  • 2022 July (Lakkireddy et al) India - Late treatment D3 60,000 IU/day

  • 2022 July (De Niet) - Belgium - Late treatment D3 25,000 IU/day

  • 2022 July (Zurita-Cruz) Mexico - Children D3 2000 IU/day

  • 2022 May (Fiore) - Italy - Late Treatment D3 100,000 IU/day

  • 2021 Nov (Beigmohammadi) - Iran/Canada - ICU pt treat D3 600,000 IU x1

  • 2021 Sep (Yildiz) - Turkey - Late Treatment D3 300,000 IU x1

User's avatar

Continue reading this post for free, courtesy of William Makis.

Or purchase a paid subscription.
© 2026 William Makis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture